Type 2 Spinal Muscular Atrophy
2 clinical trials · Condition
◉ Watch Type 2 Spinal Muscular Atrophy
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Intrathecal OAV101 (AVXS-101) in Pediatric Patients With Type 2 Spinal Muscular Atrophy (SMA) (NCT05089656) | Novartis Pharmaceuticals | 2022-02-01 |
| Prospective Study of the Natural History of Patients With Type 2 and 3 Spinal Muscular Atrophy (NCT02391831) | Institut de Myologie, France | 2015-05-01 |
Track Type 2 Spinal Muscular Atrophy automatically
Every clearance here is in the API, with alerts when new ones post.